Dermatan Sulfate

alpha-L-iduronidase ; Homo sapiens







44 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33572941 Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement. 2021 Jan 29 1
2 34360653 Differences in MPS I and MPS II Disease Manifestations. 2021 Jul 23 2
3 32188113 Mucopolysaccharidosis Type I. 2020 Mar 16 1
4 33073008 Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I. 2020 Mar 2
5 31544795 A novel compound mutation in alpha-L-iduronidase gene causes mucopolysaccharidosis type I. 2019 Sep 1
6 28676128 Phenotype prediction for mucopolysaccharidosis type I by in silico analysis. 2017 Jul 4 2
7 24368159 Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndrome. 2014 Feb 1
8 24483599 Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler. 2014 May 2
9 25459762 Lessons from molecular modeling human α-L-iduronidase. 2014 Nov 4
10 25558755 Mutation c.1190-1delG/N in intron 8 and c.1708G>C/N in exon 12 not reported in the IDUA gene developed a clinical phenotype of Scheie syndrome. 2014 Dec 1
11 27896125 Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru. 2014 2
12 27326280 Mucopolysaccharidosis type I Hurler-Scheie syndrome affecting two sisters. 2012 1
13 21521498 Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms. 2011 Apr 26 2
14 21624210 [Mutation analysis and prenatal diagnosis of 2 cases with mucopolysaccharidosis type I]. 2011 Apr 1
15 22303797 Sudden vision loss in a mucopolysaccharidosis I patient receiving enzyme replacement therapy. 2011 1
16 20162367 Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I. 2010 Apr 1
17 15639191 Prediction of neuropathology in mucopolysaccharidosis I patients. 2005 Jan 1
18 15947088 Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells. 2005 Sep 15 2
19 16283671 Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human alpha-L-iduronidase (laronidase, Aldurazyme). 2005 Dec 15 1
20 16435198 Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development. 2005 1
21 14718373 Glycosaminoglycan degradation fragments in mucopolysaccharidosis I. 2004 May 1
22 15081804 alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients. 2004 Apr 30 1
23 15236403 Prevention of neuropathology in the mouse model of Hurler syndrome. 2004 Jul 2
24 11861306 Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I. 2002 Mar 1 1
25 11405343 Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. 2001 Apr 1
26 10702409 Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly. 2000 Mar 1
27 10596456 Linkage disequilibrium between IDUA kpnI-VNTR haplotype in Mexican patients with MPS-I. 1999 Sep-Oct 2
28 9725536 Endoscopic adenoidectomy in a case of Scheie syndrome (MPS I S). 1998 Jul 10 1
29 9425437 Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts. 1997 Nov 2
30 8680403 Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. 1995 2
31 7998955 Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts. 1994 Nov 15 4
32 1301196 A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype. 1992 1
33 1301941 alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype. 1992 1
34 1505961 Structure and sequence of the human alpha-L-iduronidase gene. 1992 Aug 2
35 1550122 Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients. 1992 Apr 1
36 1917344 Airway obstruction in Hurler's syndrome--radiographic features. 1991 Jul 1
37 1946389 Human alpha-L-iduronidase: cDNA isolation and expression. 1991 Nov 1 2
38 2220820 Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3. 1990 Nov 2
39 2470345 Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies. 1989 Apr 1 1
40 6231139 Heparan sulfate and dermatan sulfate from the liver of a patient with Hurler syndrome: high performance liquid chromatography of their degradation products after incubation with alpha-L-iduronidase-deficient fibroblasts. 1984 Feb 28 1
41 6437709 alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate. 1984 Nov 1
42 6423280 Selective depolymerisation of dermatan sulfate: production of radiolabelled substrates for alpha-L-iduronidase, sulfoiduronate sulfatase, and beta-D-glucuronidase. 1983 Oct 28 2
43 102641 Fluorometric measurement of urinary alpha-L-iduronidase activity. 1978 Sep 1
44 154210 [Mucopolysaccharidosis V (Ullrich-Scheie syndrome) (author's transl)]. 1978 Dec 8 1